Published in Ophthalmology on September 01, 2009
oGVHD After Bone Marrow Transplantation: a Territory-wide Cohort | NCT05170347
Graft versus host disease: clinical evaluation, diagnosis and management. Graefes Arch Clin Exp Ophthalmol (2013) 1.00
Four cases of corneal perforation in patients with chronic graft-versus-host disease. Mol Vis (2011) 0.93
Neurological complications of transplantation: part I: hematopoietic cell transplantation. Neurohospitalist (2013) 0.84
Onset of ocular graft-versus-host disease symptoms after allogeneic hematopoietic stem cell transplantation. Cornea (2015) 0.81
Impact of Ocular Chronic Graft-versus-Host Disease on Quality of Life. Biol Blood Marrow Transplant (2015) 0.80
Incidence and risk factors for ocular GVHD after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant (2015) 0.78
Recruitment of Donor T Cells to the Eyes During Ocular GVHD in Recipients of MHC-Matched Allogeneic Hematopoietic Stem Cell Transplants. Invest Ophthalmol Vis Sci (2015) 0.77
Human albumin eye drops as a therapeutic option for the management of keratoconjunctivitis sicca secondary to chronic graft-versus-host disease after stem-cell allografting. Curr Oncol (2015) 0.77
Ocular manifestations of graft-versus-host disease. Saudi J Ophthalmol (2013) 0.77
Infectious causes of posterior uveitis and panuveitis in Thailand. Jpn J Ophthalmol (2012) 0.75
Dry Eye Disease Incidence Associated with Chronic Graft-Host Disease: Nonconcurrent Cohort Study (An American Ophthalmological Society Thesis). Trans Am Ophthalmol Soc (2015) 0.75
A Two-Piece Microkeratome-Assisted Mushroom Keratoplasty Improves the Outcomes and Survival of Grafts Performed in Eyes with Diseased Stroma and Healthy Endothelium (An American Ophthalmological Society Thesis). Trans Am Ophthalmol Soc (2015) 0.75
Regression modeling to inform cell incorporation into therapies for craniosynostosis. J Craniofac Surg (2013) 0.75
Conjunctival Acute Graft-versus-Host Disease in Adult Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Cohort Study. PLoS One (2016) 0.75
Cytomegalovirus retinitis in a patient with secondary acute lymphosarcoma leukemia undergoing allogeneic hematopoietic stem-cell transplantation: A rare case report: a care-compliant article. Medicine (Baltimore) (2017) 0.75
Prevalence of ocular hypertension and glaucoma in patients with chronic ocular graft-versus-host disease. Graefes Arch Clin Exp Ophthalmol (2016) 0.75
Ocular surface analysis in hematological patients before and after allogeneic hematopoietic stem cell transplantation: implication for daily clinical practice. Eye (Lond) (2017) 0.75
Ocular complications in children after hematopoietic stem cell transplantation without total body irradiation. Graefes Arch Clin Exp Ophthalmol (2015) 0.75
Hematopoietic stem cell transplantation: a global perspective. JAMA (2010) 3.63
Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10. Hum Mol Genet (2007) 2.61
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Biol Blood Marrow Transplant (2011) 2.11
Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI. Blood (2013) 1.54
Clinical characteristics and treatment outcome of pediatric patients with chronic myeloid leukemia. Haematologica (2010) 1.53
Enhancement of lytic activity of leukemic cells by CD8+ cytotoxic T lymphocytes generated against a WT1 peptide analogue. Leuk Lymphoma (2009) 1.47
Tuberculosis. Curr Opin Ophthalmol (2007) 1.45
Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study. Haematologica (2013) 1.36
Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors. Blood (2010) 1.33
Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups. Haematologica (2012) 1.29
Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors. Haematologica (2010) 1.27
Umbilical cord blood transplantation for children with thalassemia and sickle cell disease. Biol Blood Marrow Transplant (2011) 1.24
Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience. Blood (2013) 1.21
Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party. Blood (2012) 1.20
Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation. Blood (2014) 1.20
Influence of nucleated cell dose on overall survival of unrelated cord blood transplantation for patients with severe acquired aplastic anemia: a study by eurocord and the aplastic anemia working party of the European group for blood and marrow transplantation. Biol Blood Marrow Transplant (2010) 1.15
Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease. Am J Ophthalmol (2008) 1.08
Incidence of thyroid cancer in the Kingdom of Saudi Arabia, 2000-2010. Hematol Oncol Stem Cell Ther (2013) 1.08
Clinical characteristics and outcome of children with biphenotypic acute leukemia. Haematologica (2009) 1.07
Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita. Biol Blood Marrow Transplant (2013) 1.07
Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood? Blood (2012) 1.07
Localised Ewing sarcoma/PNET of bone--prognostic factors and international data comparison. Med Pediatr Oncol (2002) 1.05
Stem cell transplantation for chronic myeloid leukemia in children. Blood (2003) 0.94
Allogeneic hematopoietic stem cell transplantation in adolescent and adult patients with high-risk T cell acute lymphoblastic leukemia. Biol Blood Marrow Transplant (2012) 0.93
The Wilms' tumor antigen is a novel target for human CD4+ regulatory T cells: implications for immunotherapy. Cancer Res (2008) 0.91
The impact of HLA unidirectional mismatches on the outcome of myeloablative hematopoietic stem cell transplantation with unrelated donors. Blood (2013) 0.90
Imatinib (STI-571)-induced exfoliative dermatitis in a Saudi patient with deck chair sign. Dermatology (2003) 0.88
Myeloid sarcoma of the vulva post-bone marrow transplant presenting as isolated extramedullary relapse in a patient with acute myeloid leukemia. Hematol Oncol Stem Cell Ther (2012) 0.88
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Rev Bras Hematol Hemoter (2012) 0.86
Synergistic effects of honey and propolis toward drug multi-resistant Staphylococcus aureus, Escherichia coli and Candida albicans isolates in single and polymicrobial cultures. Int J Med Sci (2012) 0.86
Prevention of ligneous conjunctivitis by topical and subconjunctival fresh frozen plasma. Am J Ophthalmol (2004) 0.85
Long-term survival and late deaths after hematopoietic cell transplantation for primary immunodeficiency diseases and inborn errors of metabolism. Biol Blood Marrow Transplant (2012) 0.84
Bone marrow oxalosis. Blood (2012) 0.84
Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2008-2009: report on behalf of the Eastern Mediterranean Bone Marrow Transplantation (EMBMT) Group. Hematol Oncol Stem Cell Ther (2011) 0.84
Outcome of aplastic anaemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant. Br J Haematol (2015) 0.84
Honey and cardiovascular risk factors, in normal individuals and in patients with diabetes mellitus or dyslipidemia. J Med Food (2013) 0.83
Defecation of a "colon cast" as a rare presentation of acute graft-versus-host disease. Ann Saudi Med (2009) 0.83
Molecular epidemiology of adenoviral keratoconjunctivitis in Saudi Arabia. Mol Vis (2010) 0.83
Trisomy 4 as the sole karyotypic abnormality in a case of acute biphenotypic leukemia with T-lineage markers in minimally differentiated acute myelocytic leukemia. Cancer Genet Cytogenet (2004) 0.82
Fludarabine-based conditioning chemotherapy for allogeneic hematopoietic stem cell transplantation in acquired severe aplastic anemia. Biol Blood Marrow Transplant (2010) 0.81
Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency. Biol Blood Marrow Transplant (2010) 0.81
High efficacy and low toxicity of short-course oral valganciclovir as pre-emptive therapy for hematopoietic stem cell transplant cytomegalovirus infection. Hematol Oncol Stem Cell Ther (2010) 0.81
Successful treatment of steroid-refractory autoimmune thrombocytopenia associated with Castleman disease with anti-CD-20 antibody (rituximab). Hematol Oncol Stem Cell Ther (2011) 0.81
Autologous bone marrow transplanation for extramedullary plasmacytoma presenting as adrenal incidentaloma. Ann Saudi Med (2009) 0.81
Trends of hematopoietic stem cell transplantation in the Eastern Mediterranean region, 1984-2007. Biol Blood Marrow Transplant (2011) 0.80
Ongoing graft-versus-host disease is a risk factor for azoospermia after allogeneic hematopoietic stem cell transplantation: a survey of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Haematologica (2012) 0.79
HLA-matched sibling transplantation for severe aplastic anemia: impact of HLA DR15 antigen status on engraftment, graft-versus-host disease, and overall survival. Biol Blood Marrow Transplant (2012) 0.79
Efficacy of vincristine and carboplatin as chemo-reduction for advanced bilateral retinoblastoma, the Saudi experience. Saudi J Ophthalmol (2013) 0.79
Squamous cell carcinoma of the lip after allogeneic hemopoietic stem cell transplantation. Hematol Oncol Stem Cell Ther (2010) 0.79
Hematopoietic stem cell transplantation practice variation among centers in the Eastern Mediterranean Region (EMRO): Eastern Mediterranean Bone Marrow Transplantation (EMBMT) group survey. Hematol Oncol Stem Cell Ther (2013) 0.79
Identification of Gaucher disease mutations found in Saudi Arabia. Blood Cells Mol Dis (2008) 0.79
Training practices of hematopoietic progenitor cell-apheresis and -cord blood collection staff: analysis of a survey by the Alliance for Harmonisation of Cellular Therapy Accreditation. Transfusion (2014) 0.78
The challenge of risk stratification in acute myeloid leukemia with normal karyotype. Hematol Oncol Stem Cell Ther (2010) 0.78
Cancer prevention and control in the Eastern Mediterranean region: the need for a public health approach. Hematol Oncol Stem Cell Ther (2010) 0.78
Outcome of pediatric patients with lymphoma following stem cell transplant: a single institution report. Leuk Lymphoma (2014) 0.78
Acquisition of vernal and atopic keratoconjunctivitis after bone marrow transplantation. Am J Ophthalmol (2008) 0.78
[Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation]. Rinsho Ketsueki (2014) 0.78
Effect of jujube honey on Candida albicans growth and biofilm formation. Arch Med Res (2013) 0.78
Obliterative bronchiolitis in a patient with myelodysplastic syndrome before bone marrow transplantation. Respir Med (2006) 0.78
Ocular manifestations of graft-versus-host disease. Saudi J Ophthalmol (2013) 0.77
Maternal acute lymphoctic leukemia with rearrangement of the mixed lineage leukemia gene occurring during pregnancy. Hematol Oncol Stem Cell Ther (2009) 0.77
Allogeneic hematopoietic stem cell transplantation in leukocyte adhesion deficiency type 1: a single center experience. Biol Blood Marrow Transplant (2011) 0.77
Identification of a novel peptide derived from the M-phase phosphoprotein 11 (MPP11) leukemic antigen recognized by human CD8+ cytotoxic T lymphocytes. Hematol Oncol Stem Cell Ther (2010) 0.76
Is rasburicase needed for prevention of tumor lysis syndrome during treatment of less aggressive hematolymphoid malignancies? J Clin Oncol (2004) 0.76
Status of hematopoietic stem cell transplantation in the WHO Eastern Mediterranean Region (EMRO). Transfus Apher Sci (2010) 0.76
Gastroesophageal reflux disease and its association with bronchiolitis obliterans syndrome in allogeneic hematopoietic stem cell transplant recipients. Exp Clin Transplant (2013) 0.76
In cyclosporine induced neurotoxicity, is tacrolimus an appropriate substitute or is it out of the frying pan and into the fire? Pediatr Blood Cancer (2008) 0.75
Birth order and transplantation outcome in HLA-identical sibling stem cell transplantation: an analysis on behalf of the Center for International Blood and Marrow Transplantation. Biol Blood Marrow Transplant (2013) 0.75
Determination of acaricide residues in saudi arabian honey and beeswax using solid phase extraction and gas chromatography. J Environ Sci Health B (2006) 0.75
Leukemia relapse after allogeneic bone marrow transplantation: how does chronic graft-versus-host disease influence the pattern and onset of relapse? Exp Clin Transplant (2011) 0.75
Factors Determining the Outcome of Hematopoietic Stem Cell Transplantation in Patients With Acute Lymphoblastic Leukemia at King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. J Pediatr Hematol Oncol (2016) 0.75
The t(9;11) confers good prognosis in AML patients treated with stem cell transplantation as compared to non-t(9;11) and other adverse-risk abnormalities. Hematol Oncol Stem Cell Ther (2012) 0.75
Brief Biography of Guest Editors of SI of SJBS. Saudi J Biol Sci (2017) 0.75
Outcome of risk adapted therapy for relapsed/refractory acute lymphoblastic leukemia in children. Leuk Lymphoma (2012) 0.75